What Is the Best Sirtuin Assay for SIRT Screening?
Quick Answer
There may be no best sirtuin assay as each assay has strengths and weaknesses that are a fit for different applications. One of the best sirtuin assays for high-throughput screening (HTS) and lead optimization is the Transcreener OAADPr SIRT Assay from BellBrook Labs.
Unlike fluorogenic peptide or radiometric assays, it measures the universal reaction product of sirtuin-catalyzed deacetylation — 2′-O-acetyl-ADP-ribose (OAADPr) — using a simple, homogeneous, mix-and-read format.
This approach eliminates substrate artifacts, improves physiological relevance, and provides robust performance (Z′ ≥ 0.7) for reliable hit identification in 384- and 1536-well formats.
Learn more about the Transcreener OAADPr SIRT Assay →
Why Sirtuin Assays Matter
Sirtuins at the Crossroads of Health, Longevity, and Disease
Sirtuins (SIRT1-SIRT7) are NAD⁺-dependent deacetylases or deacylases that regulate critical cellular processes including metabolism, DNA repair, inflammation, and aging.
Their enzymatic mechanism couples substrate deacetylation to NAD⁺ cleavage, producing nicotinamide and OAADPr.
Because sirtuins influence such broad pathways, they’ve become prime drug targets in areas like:
- Neurodegenerative disease: SIRT1 activation has shown neuroprotective effects in Alzheimer’s and Parkinson’s models.
- Metabolic disorders: SIRT1 and SIRT3 regulate glucose homeostasis and lipid metabolism.
- Cancer: SIRT2 and SIRT6 modulate genome stability, tumor suppression, and metabolic reprogramming.
- Inflammation and immunity: SIRT1 and SIRT6 act as transcriptional repressors of pro-inflammatory genes.
Developing selective small-molecule inhibitors or activators of these enzymes could open entirely new therapeutic strategies. But success starts with having a sensitive, accurate, and high-throughput biochemical assay to measure sirtuin activity.
The Role of Sirtuin Assays in Drug Discovery
After a target is validated, biochemical assays are the foundation for HTS campaigns — they measure enzyme activity in the presence of thousands of compounds to find activators or inhibitors.
A well-designed sirtuin assay should:
- Reliably detect enzymatic turnover at initial-velocity conditions
- Support 384- or 1536-well plates for HTS
- Be robust, reproducible, and cost-efficient
- Avoid false positives from fluorescence or coupling artifacts
- Work across SIRT1, SIRT2, SIRT3 and other isoforms
- Translate into lead optimization and selectivity profiling
Poor assay design leads to false hits, wasted screening resources, and misleading structure-activity relationships (SAR). In contrast, a robust universal assay like Transcreener OAADPr ensures confidence in both data quality and downstream decisions.
Major Types and Formats of Sirtuin Assays
Over the past two decades, several sirtuin assay technologies have emerged. Each detects either substrate conversion or product formation using different readouts. Below are the most common assay types and their characteristics.
| Format | Principle / Readout | Advantages | Disadvantages |
|---|---|---|---|
| Radiometric assays | Radioactively labeled acetyl-lysine substrate; release of radiolabeled acetate upon deacetylation | Direct measurement, very sensitive, low background | Hazardous materials, costly waste handling, not HTS-friendly |
| Fluorescent peptide assays (e.g., Fluor-de-Lys) | Acetylated peptide tagged with a fluorophore; after deacetylation, a developer protease releases fluorescence | Simple, moderate throughput, commercial availability | Two-step reaction, developer dependency, substrate artifacts |
| FRET/TR-FRET immunoassays | Antibody-based detection of acetylated peptide; signal changes upon deacetylation | Homogeneous, scalable, automation-ready | Antibody cost, potential compound interference, substrate limitations |
| Label-free HPLC or LC-MS assays | Direct detection of OAADPr or deacetylated peptide by chromatography/mass spectrometry | High specificity, physiologically relevant | Low throughput, labor-intensive, expensive instrumentation |
| Biochemical enzyme assays (e.g., Transcreener OAADPr) | Measures OAADPr product via coupling enzyme and fluorescent tracer displacement | Mix-and-read, high throughput, detects native product, robust | Biochemical only (not cellular) |
Comparing Sirtuin Assay Formats
| Criteria | Radiometric | Fluorescence Peptide | FRET/TR-FRET | Label-Free (HPLC/MS) | Transcreener OAADPr SIRT Assay |
|---|---|---|---|---|---|
| Throughput | Low | Medium–High | High | Low | Very High |
| Homogeneous (no wash) | No | Sometimes | Yes | No | Yes |
| Physiological Relevance | High | Moderate | Moderate–High | High | High |
| False-Positive Risk | Low | Higher (fluorophore interference) | Moderate | Low | Low |
| Ease of Automation | Poor | Good | Excellent | Poor | Excellent |
| Detection of Native Product | Yes | No | No | Yes | Yes |
| Cost per Well | Moderate | Low–Medium | Medium | High | Low – Medium |
| Best Use Case | Mechanistic enzymology | Early screening, teaching labs | Screening large compound sets | Validation, kinetics | HTS, hit validation, lead optimization |
What Defines the “Best” Sirtuin Assay?
When scientists evaluate assays for sirtuin inhibitor or activator screening, the following parameters typically define “best” in practice:
- Universality across isoforms: Works for multiple SIRT enzymes (SIRT1, SIRT2, SIRT3, etc.) without extensive redevelopment.
- Robustness and reproducibility: High Z′ factor (> 0.7), stable baseline, and low variability.
- Physiological relevance: Uses native NAD⁺ and acetylated peptide substrates; detects natural products.
- Homogeneous and HTS-friendly: Minimal steps, no separations, compatible with automation.
- Low interference risk: Resistant to compound fluorescence, quenching, or color effects.
- Sensitivity and dynamic range: Accurately measures enzyme activity at low turnover.
- Low reagent cost and ease of scale-up: Practical for 100,000+ compound campaigns.
- Flexibility for activator vs inhibitor mode: Detects both types accurately.
- Compatibility with downstream assays: Biochemical hits can easily bridge into cellular or biophysical assays.
The Transcreener OAADPr SIRT Assay consistently meets these benchmarks better than most conventional methods.
The Case for Transcreener OAADPr SIRT Assay
A Universal Product Detection Strategy
The Transcreener OAADPr SIRT Assay directly detects the common product of all sirtuin reactions — 2′-O-acetyl-ADP-ribose (OAADPr) — using BellBrook Labs’ proprietary competitive immunoassay technology.
Because OAADPr is generated in equimolar ratio to substrate deacetylation, measuring it provides a direct readout of enzyme activity without engineered tags or secondary protease steps.
This approach ensures:
- Native enzymology: true representation of NAD⁺-coupled deacetylation
- Universal application: suitable for any sirtuin (SIRT1–SIRT7) that generates OAADPr
- Reduced artifacts: limited fluorescent or radiolabel interference
Homogeneous, Mix-and-Read Workflow
Traditional assays often require multiple steps — substrate incubation, developer addition, wash or separation — all of which introduce variability.
The Transcreener assay is a single-addition, homogeneous format: enzyme reaction → add detection mix → read plate.
That simplicity enables rapid scaling to hundreds of plates per day on standard HTS infrastructure with either:
- Fluorescence Polarization (FP) readout, or
- Time-Resolved Förster Resonance Energy Transfer (TR-FRET) readout for higher sensitivity.
Superior Performance Metrics
- Z′ factor: ≥ 0.7 in 384-well format (validated with SIRT1, SIRT2, and SIRT3)
- Signal window: > 100 mP shift (FP mode)
- Dynamic range: spans > 1.5 logs of enzyme activity
- Assay time: ≤ 90 minutes total
- Detection limit: down to 100 nM OAADPr
These characteristics provide the reliability needed for large screening campaigns where small signal drift could otherwise misclassify hits.
Minimized False Positives
Because the Transcreener assay reads in the far-red spectrum, it reduces interference from fluorescent compounds common in drug libraries.
Moreover, it detects the product rather than using a tagged substrate, which eliminates activation artifacts previously reported for certain SIRT1 fluorescent peptide assays.
Broad Applicability
Validated for SIRT1, SIRT2, and SIRT3, the assay can be adapted for other NAD⁺-dependent sirtuins such as SIRT5 or SIRT6 with minimal optimization, making it a cost-effective universal platform for enzyme profiling.
Ready for Automation
The Transcreener format is compatible with standard liquid-handling robots, multi-mode readers, and data analysis software.
Its mix-and-read design means no centrifugation, washing, or radioactivity handling, which simplifies validation and makes it ideal for CROs, pharma, and biotech screening groups.
Use Cases and Practical Applications
-
Primary Screening:
Run large compound HTS campaigns against SIRT1, SIRT2, or SIRT3 using 384- or 1536-well plates.
Rapid turnaround, robust signal, and reduced interference make it ideal for primary hit discovery. -
Hit Confirmation and SAR Studies:
Perform IC₅₀ or EC₅₀ determinations under initial-velocity conditions.
Consistent product detection ensures accurate ranking of actives. -
Isoform Selectivity Profiling:
Extend the same detection chemistry across SIRT1–SIRT7 for comparative screening.
Identifying selective activators or inhibitors is crucial for therapeutic targeting. -
Mechanism-of-Action Exploration:
Couple the Transcreener assay to kinetic analysis (Kᵢ determination, substrate competition) or orthogonal methods (HPLC, MS) for comprehensive characterization. -
HTS-CRO Integration:
CRO partners can easily integrate Transcreener technology into existing HTS workflows for client projects, reducing assay development time.
Comparison Snapshot: Transcreener vs Other Assay Kits
| Feature | Fluor-de-Lys | HTRF SIRT1 Assay (Revvity) | OAADPr Transcreener (BellBrook Labs) |
|---|---|---|---|
| Detection Principle | Tagged substrate + developer protease | Antibody-based TR-FRET detection of acetyl-peptide | Competitive immunoassay measuring OAADPr |
| Homogeneous Format | Two-step | Yes | Yes (single-addition) |
| Native Product Detection | No | No | Yes |
| Isoform Coverage | SIRT1, limited | SIRT1 | SIRT1, SIRT2, SIRT3 adaptable for others |
| Throughput | Medium | High | Very High (384/1536) |
| Z′ Factor | 0.5–0.6 typical | ~0.6 | ≥ 0.7 |
| Interference Risk | High (fluorescent artifacts) | Moderate | Low (far-red FP/TR-FRET) |
| Best For | Academic use, pilot screens | Screening, profiling | HTS, lead optimization, CRO integration |
Tips for Selecting the Right Sirtuin Assay
-
Match the format to your goal.
-
Mechanistic enzymology → radiometric or HPLC
-
HTS and lead discovery → homogeneous FP or TR-FRET
-
Orthogonal validation → LC-MS or cellular
-
-
Consider biological relevance.
Detecting native products like OAADPr provides better correlation to true enzyme function than peptide tags. -
Check interference and Z′ values early.
Screen pilot plates with test libraries to ensure the window is adequate. -
Plan for scalability.
Choose assays validated in 384/1536 formats and automation-ready to avoid re-development. -
Pair biochemical assays with cellular follow-ups.
Even the best in-vitro assay should be complemented by cellular readouts for functional confirmation.
Conclusion
Sirtuins remain among the most intriguing and therapeutically relevant enzyme families in drug discovery — but measuring their activity accurately has long been a technical challenge.
Among all available formats, the Transcreener OAADPr SIRT Assay stands out because it:
- Detects the native enzymatic product (OAADPr)
- Offers robust Z′ values and reproducibility in miniaturized HTS formats
- Operates as a single-addition, mix-and-read method compatible with automation
- Reduces false positives from tagged substrates or fluorescent compounds
- Provides a universal detection strategy adaptable across sirtuin isoforms
For researchers, CROs, and screening facilities aiming to accelerate sirtuin modulator discovery, it represents the most balanced combination of biological relevance, performance, and practical usability available today.
Explore the Transcreener OAADPr SIRT Assay →
Frequently Asked Questions (FAQs)
Q1. What exactly does the Transcreener OAADPr SIRT Assay measure?
It measures 2′-O-acetyl-ADP-ribose (OAADPr), the direct product of the NAD⁺-dependent deacetylation reaction catalyzed by sirtuins. Detection is achieved via a competitive immunoassay using fluorescent tracer displacement.
Q2. Does it work for all sirtuin isoforms?
Yes, it’s validated for SIRT1, SIRT2, and SIRT3 and can be readily adapted for other sirtuins (SIRT4-SIRT7) since all produce OAADPr as a reaction product.
Q3. How does it compare to Fluor-de-Lys assays?
Fluor-de-Lys assays use peptide substrates modified with fluorophores and require a developer enzyme step. While inexpensive, they can suffer from substrate artifacts and false activation signals. Transcreener directly detects the native product, avoiding these issues.
Q4. What readout modes are available?
The assay is available in both fluorescence polarization (FP) and TR-FRET formats. FP offers simplicity and broad accessibility, while TR-FRET provides enhanced lower background.
Q5. What Z′ factor should I expect?
Typically ≥ 0.7 for SIRT1 and SIRT2 under optimized conditions — indicating excellent assay robustness for HTS.
Q6. Are there known interference issues?
Far-red emission minimizes compound auto-fluorescence interference. The homogeneous mix-and-read design avoids multi-step errors or enzymatic coupling artifacts.
Q7. Can I use it for activator screens as well as inhibitors?
Yes. The OAADPr product formation increases with both activators (enhanced deacetylation) and inhibitors (reduced turnover), enabling detection in either direction.
Q8. Is it suitable for kinetic or endpoint analysis?
Both. You can use kinetic sampling for mechanism studies or single-endpoint reads for throughput screens.
Q9. How is it different from cellular sirtuin assays?
It’s a purified-enzyme biochemical assay, not a cellular format. Cellular assays are typically used later to validate biochemical hits for activity and permeability.
Q10. What are typical reaction conditions?
Reactions are run at physiological NAD⁺ concentrations with acetylated peptide substrates (e.g., H3K9Ac (1-21) peptide). Reaction times typically range from 30–60 minutes depending on enzyme concentration and turnover.
